Randall Kaye

Randall Kaye is the Chief Medical Officer, bringing a wealth of experience in clinical development and medical affairs. He previously served as Chief Scientific Officer for SSI Strategy and was the Chief Medical Officer for Axsome Therapeutics and Avanir Pharmaceuticals. At Avanir Pharmaceuticals, he focused on providing leadership and vision to clinical development and medical affairs. Before that, he was Vice President of Medical Affairs for Scios Inc., where he built and integrated a Medical Affairs department. He also recruited and managed the Medical Affairs department for InterMune Inc. and served in various Clinical Development and Medical Affairs positions at Pfizer Inc. for nearly a decade. Randall Kaye earned his M.D., M.P.H., and B.S. degrees at George Washington University and was a Research Fellow in Allergy and Immunology at Harvard Medical School.